Aquestive Therapeutics (AQST) Common Equity (2017 - 2026)
Aquestive Therapeutics (AQST) posted quarterly Common Equity of -$34.1 million for Q1 2026, up 44.11% year-over-year from -$23.6 million in Q1 2025, and down 1.16% quarter-over-quarter from -$33.7 million in Q4 2025.
Aquestive Therapeutics (AQST) Common Equity (2017 - 2026) Analysis & Trends
Aquestive Therapeutics' Common Equity history runs 10 years deep, the most recent figure standing at -$34.1 million for Q1 2026.
- In Q1 2026, Common Equity rose 44.11% year-over-year to -$34.1 million; the TTM figure through Mar 2026 stood at -$34.1 million (up 44.11% YoY), while the FY2025 annual figure was -$33.7 million, up 44.04% from the prior year.
- Common Equity for Q1 2026 stood at -$34.1 million, down from -$33.7 million in the prior quarter.
- The five-year high for Common Equity was -$4.1 million in Q3 2025, with the low at -$118.6 million in Q4 2022.
- The 5-year median for Common Equity is -$72.6 million (2025), against an average of -$72.0 million.
- Peak annual rise in Common Equity reached 90.95% in 2025, while the deepest fall reached 104.6% in 2025.
- Aquestive Therapeutics' Common Equity stood at -$118.6 million in 2022, then increased by 10.18% to -$106.5 million in 2023, then surged by 43.51% to -$60.2 million in 2024, then jumped by 44.04% to -$33.7 million in 2025, then decreased by 1.16% to -$34.1 million in 2026.
- Business Quant data shows AQST's Common Equity at -$34.1 million in Q1 2026, -$33.7 million in Q4 2025, and -$4.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | 22.06 Bn |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.32 Bn | 2.15 Bn | 7.76 Bn |
| 3 | Zoetis | 31.53 Bn | 29.86 Bn | 1.05 Bn | 3.15 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 47.42 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 6.40 Bn |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn | 14.26 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 3.69 Bn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 6.59 Bn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | 4.05 Bn |
| 10 | Aquestive Therapeutics | 554.85 Mn | 554.85 Mn | 9.80 Mn | -56.59 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -56.59 Mn |
| Mar 31, 2026 | -34.05 Mn |
| Dec 31, 2025 | -33.66 Mn |
| Sep 30, 2025 | -4.11 Mn |
| Jun 30, 2025 | -72.59 Mn |
| Mar 31, 2025 | -60.93 Mn |
| Dec 31, 2024 | -60.16 Mn |
| Sep 30, 2024 | -45.42 Mn |
| Jun 30, 2024 | -35.48 Mn |
| Mar 31, 2024 | -36.30 Mn |
| Dec 31, 2023 | -106.49 Mn |
| Sep 30, 2023 | -102.93 Mn |
| Jun 30, 2023 | -106.65 Mn |
| Mar 31, 2023 | -109.24 Mn |
| Dec 31, 2022 | -118.55 Mn |
| Sep 30, 2022 | -107.82 Mn |
| Jun 30, 2022 | -96.36 Mn |
| Mar 31, 2022 | -93.14 Mn |
| Dec 31, 2021 | -82.13 Mn |
| Sep 30, 2021 | -60.35 Mn |